MediPharm Labs Corp (MEDIF)

[FUNMAN]

In this case take a look at the balance sheet and follow the news.

MediPharm has a strong balance sheet and cut "pandemic-costs" AFTER shaving some of the post-Canadian-cannabis-contraction that was right-sizing some of the companies.

MediPharm isn't going out of business. They pivoted, developing their own product lines, and have been in firm pursuit of the international markets, securing their GMP Licence opening access to the 500M EU.

They stumbled in the new and emerging Canadian cannabis business and took one on the chin. They got up, dusted themselves off, and started announcing new international deals that were the original business plan goal.

Their aim was never to be a Canadian producer for Canadian markets exclusively. It was always to be an international supplier and they are executing.

As for the disconnect between the PPS and the new deal announcements, as Bill Parcells used to say about a team and where they stood, you are what your record says you are.

MediPharm's trailing revenues were cut by 2/3's. No one thinks they should be rewarded for that.

However, as a keen follower of MediPharm, the deals they are announcing are in much bigger and growing Cannabis markets than Canada. Particularly Brazil.

So now we need to be patient. Revenues from new deals should lag by 1 - 2 Qs.

When they show The Street they have their legs back under them, people will start buying the essential service companies again.